HIGHLIGHTS
- who: C O L D and colleagues from the Laboratory Press have published the Article: Case report: olaparib use in metastatic lung adenocarcinoma with BRCA2 pathogenic variant, in the Journal: (JOURNAL)
- how: The extracted DNA then undergoes polymerase_chain_reaction (PCR) amplification for exons 18 19 20 and 21 and the following mutations screened for in the assay are shown in the Supplemental Materials.
SUMMARY
Since the discovery of oncogenic driver mutations, the therapeutic landscape of non-smallcell lung cancer (NSCLC) has evolved exponentially. The Cancer Genome Atlas data set, the rates of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.